HIV

Callista Images | Image Source | Getty ImagesNew HIV infections declined modestly in the U.S. over a four-year period but the nation is far from reaching its goal of ending the epidemic, according to the most recent data published by the…

New research from Boston Medical Center found that people living with HIV that have had pulmonary tuberculosis had broader and more potent HIV antibody responses and differences in HIV sequences predicted to be antibody resistant as…

The logo of Gilead Sciences pharmaceutical company is seen in Oceanside, California, April 29, 2020.Mike Blake | ReutersA Delaware jury on Tuesday cleared Gilead Sciences of U.S. government allegations that it violated patents held by the…

Gene-editing therapy aimed at two targets -- HIV-1, the virus that causes AIDS, and CCR5, the co-receptor that helps the virus get into cells -- can effectively eliminate HIV infection, new research from the Lewis Katz School of Medicine at…

Gilead Sciences logo displayed on a laptop screen and medical pills are seen in this illustration photo taken in Krakow, Poland on October 18, 2021. (Photo by Jakub Porzycki/NurPhoto via Getty Images)Nurphoto | Nurphoto | Getty ImagesGilead…

A new HIV vaccine from Scripps Research has shown a significantly improved ability to neutralize the virus in preclinical tests, and it will soon be studied in healthy people who volunteer to participate in clinical trials. The new and…

The identity of the fifth-ever patient to enter full remission for HIV has been revealed to the public.Paul Edmonds, 67, of Desert Hot Springs, California, around 100 miles east of Los Angeles, was cured of the disease in July. At the time,…

The report based on research by the Economist Impact partnership across 13 African countries, A Triple Dividend: The health, social and economic gains from financing the HIV response in Africa, estimates that millions of lives will also be…

Despite calls for the federal government to take immediate action to eradicate human immunodeficiency virus (HIV) in Canada, the 2023 budget fell short of offering new funding — and didn’t reference HIV once. In the 41 years since the…

The United Nations-backed public health organisation Medicines Patent Pool has signed sublicense agreements with Aurobindo Pharma, Cipla and Viatris (through its subsidiary Mylan) under which the drugmakers will manufacture generic versions…